Affiliation:
1. Department of Otolaryngology–Head and Neck Surgery, Columbia University, New York, New York
2. Department of Mechanical Engineering, Columbia University, New York, New York
3. Department of Biomedical Engineering, Columbia University, New York, New York
Abstract
Hypothesis
Microneedle-mediated intracochlear injection of siRNA-Lipofectamine through the round window membrane (RWM) can be used to transfect cells within the cochlea.
Background
Our laboratory has developed 100-μm diameter hollow microneedles for intracochlear injection through the guinea pig RWM. In this study, we test the feasibility of microneedle-mediated injection of siRNA and Lipofectamine, a commonly used reagent with known cellular toxicity, through the RWM for cochlear transfection.
Methods
Fluorescently labeled scramble siRNA was diluted into Lipofectamine RNAiMax and OptiMEM. One microliter of 5 μM siRNA was injected through the RWM of Hartley guinea pigs at a rate of 1 μl/min (n = 22). In a control group, 1.0 μl of Lipofectamine, with no siRNA, was diluted into OptiMEM and injected in a similar fashion (n = 5). Hearing tests were performed before and either at 24 hours, 48 hours, or 5 days after injection. Afterward, animals were euthanized, and cochleae were harvested for imaging. Control cochleae were processed in parallel to untreated guinea pigs.
Results
Fluorescence, indicating successful transfection, was observed within the basal and middle turns of the cochlea with limited distribution in the apex at 24 and 48 hours. Signal was most intense in the organ of Corti, spiral ligament, and spiral ganglion. Little to no fluorescence was observed at 5 days post-injection. No significant changes in auditory brainstem response (ABR) were noted post-perforation at 5 days, suggesting that siRNA-Lipofectamine at low doses does not cause cochlear toxicity.
Conclusions
Small volumes of siRNA and Lipofectamine can be effectively delivered to cochlear structures using microneedles, paving the way for atraumatic cochlear gene therapy.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference37 articles.
1. Hearing difficulties among adults: United States, 2019;NCHS Data Brief,2021
2. Hearing loss and cognitive decline in older adults;JAMA Intern Med,2013
3. Hearing impairment and incident dementia and cognitive decline in older adults: The Health ABC study;J Gerontol A Biol Sci Med Sci,2017
4. Association of age-related hearing loss with cognitive function, cognitive impairment, and dementia: A systematic review and meta-analysis;JAMA Otolaryngol Head Neck Surg,2018
5. Synaptopathy in the noise-exposed and aging cochlea: Primary neural degeneration in acquired sensorineural hearing loss;Hear Res,2015